{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:17:15Z","timestamp":1792491435769,"version":"4.5.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"\n Background<\/jats:title>\n Adolescence is a period of high incidence for depression. However, there is a limited treatment option for the adolescent depression. For treatment-resistant major depressive disorder, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) appears therapeutically effective. The aim of the study is to explore the early effects of repetitive transcranial magnetic stimulation in combination with sertraline in adolescents with first-episode major depressive disorder.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A total of 100 teenage patients with first-episode depression were randomly divided into the study groups. Both groups were treated with sertraline. In addition, the study group was treated with ten sessions of add-on rTMS. The control group was given sertraline only. The depressive symptom and cognitive function were assessed by the Hamilton depression rating scale 17 version (HAMD-17), Children\u2019s Depression Rating Scale-Revised (CDRS-R), Integrated visual and auditory continuous performance test (IVA-CPT), and THINC-it.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The number of early improvers after 2 weeks of treatment in the study group was statistically significant higher compared to the control group (95.83% vs 73.47%, \u03c7\n 2<\/jats:sup>\n = 9.277,\n P<\/jats:italic>\n = 0.002). There was significant difference observed in responder rates (62.50% vs. 28.57%, \u03c7\n 2<\/jats:sup>\n = 11.262,\n P<\/jats:italic>\n = 0.001) or in remission rates (31.25% vs. 6.12%, \u03c7\n 2<\/jats:sup>\n = 10.130,\n P<\/jats:italic>\n = 0.001) between the two groups at 4 weeks. The score of HAMD-17 and CDRS-R in the study group were significantly lower than the control group (F\n group<\/jats:sub>\n = 12.91 vs 10.21,\n P<\/jats:italic>\n &lt; 0.05). Attention Quotient (listening, visual and full-scale) attention quotient of IVA-CPT in the study group were higher than those in the control group after treatment, and the differences were statistically significant(\n P<\/jats:italic>\n &lt; 0.05). The study group showed higher score in Spotter than the control group after treatment (\n P<\/jats:italic>\n &lt; 0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n This is the most extensive blinded, randomized clinical study to date examining the efficacy of 10-Hz add-on rTMS for first-onset adolescent depression. Our results support that add-on rTMS accelerates the efficacy of the antidepressants, improving the depressive symptoms and cold cognitive function in first-episode adolescent depression.<\/jats:p>\n <\/jats:sec>\n \n Clinical Trial Registration<\/jats:title>\n \n [\n www.ClinicalTrials.gov<\/jats:ext-link>\n ], identifier [ChiCTR2100048534].\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpsyt.2022.853961","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:13:14Z","timestamp":1658196794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Early Effects of Repetitive Transcranial Magnetic Stimulation Combined With Sertraline in Adolescents With First-Episode Major Depressive Disorder"],"prefix":"10.3389","volume":"13","author":[{"given":"Haisi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaole","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjc.12333","article-title":"Global prevalence of depression and elevated depressive symptoms among adolescents: a systematic review and meta-analysis.","volume":"61","author":"Shorey","year":"2022","journal-title":"Br J Clin Psychol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1017\/S0033291709991036","article-title":"How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment.","volume":"40","author":"Moffitt","year":"2010","journal-title":"Psychol Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/archgenpsychiatry.2009.85","article-title":"Childhood and adolescent psychiatric disorders as predictors of young adult disorders.","volume":"66","author":"Copeland","year":"2009","journal-title":"Arch Gen Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(11)60871-4","article-title":"Depression in adolescence.","volume":"379","author":"TThapar","year":"2012","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.psc.2016.04.002","article-title":"Antidepressants and suicidality.","volume":"39","author":"Brent","year":"2016","journal-title":"Psychiatr Clin North Am."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6699028","article-title":"Use of antidepressants among patients diagnosed with depression: a scoping review.","volume":"2021","author":"Marasine","year":"2021","journal-title":"Biomed Res Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1001\/jamapsychiatry.2016.3644","article-title":"Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis.","volume":"74","author":"Brunoni","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jad.2020.01.068","article-title":"Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.","volume":"265","author":"Corlier","year":"2020","journal-title":"J Affect Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.brs.2016.03.010","article-title":"The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder.","volume":"9","author":"Perera","year":"2016","journal-title":"Brain Stimul."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.brs.2018.09.007","article-title":"Add-on rTMS for the acute treatment of depressive symptoms is probably more effective in adolescents than in adults: evidence from real-world clinical practice.","volume":"12","author":"Zhang","year":"2019","journal-title":"Brain Stimul."},{"key":"B11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jad.2020.09.058","article-title":"Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in adolescence: a systematic review.","volume":"278","author":"Hett","year":"2021","journal-title":"J Affect Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41386-020-00829-y","article-title":"Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.","volume":"46","author":"Croarkin","year":"2021","journal-title":"Neuropsychopharmacology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jcph.710","article-title":"Early improvements in individual symptoms to predict later remission in major depressive disorder treated with mirtazapine.","volume":"56","author":"Funaki","year":"2016","journal-title":"J Clin Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/13854046.2015.1063695","article-title":"Attention in older adults: a normative study of the integrated visual and auditory continuous performance test for persons aged 70 years.","volume":"29","author":"Berginstr\u00f6m","year":"2015","journal-title":"Clin Neuropsychol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4088\/JCP.16m11329","article-title":"Integrated tool (THINC-it) screening assessment for cognitive dysfunction.","volume":"78","author":"McIntyre","year":"2017","journal-title":"J Clin Psychiatry."},{"key":"B16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jad.2020.03.146","article-title":"PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder.","volume":"273","author":"Hou","year":"2020","journal-title":"J Affect Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.2147\/NDT.S266642","article-title":"Reliability and validity of THINC-it in evaluating cognitive function of patients with bipolar depression.","volume":"16","author":"Zhang","year":"2020","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1570159X18666200221113134","article-title":"Repetitive transcranial magnetic stimulation combined with antidepressants for the first episode of major depressive disorder.","volume":"18","author":"Maneeton","year":"2020","journal-title":"Curr Neuropharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0004867411433216","article-title":"Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.","volume":"46","author":"Huang","year":"2012","journal-title":"Aust N Z J Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psychres.2017.04.005","article-title":"Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder.","volume":"254","author":"Wang","year":"2017","journal-title":"Psychiatry Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00170","article-title":"Repetitive transcranial magnetic stimulation in youth with treatment resistant major depression.","volume":"10","author":"MacMaster","year":"2019","journal-title":"Front Psychiatry."},{"key":"B22","first-page":"320","article-title":"No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled \u201cadd on\u201d trial.","volume":"75","author":"Hausmann","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1017\/S0033291707001663","article-title":"A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.","volume":"38","author":"Mogg","year":"2008","journal-title":"Psychol Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/da.22658","article-title":"Cognitive enhancing effects of rTMS administered to the prefrontal cortex in patients with depression: a systematic review and meta-analysis of individual task effects.","volume":"34","author":"Martin","year":"2017","journal-title":"Depress Anxiety."},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression.","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv059","article-title":"Abnormal anterior cingulate N-acetylaspartate and executive functioning in treatment-resistant depression after rTMS therapy.","volume":"18","author":"Zheng","year":"2015","journal-title":"Int J Neuropsychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2018.00128","article-title":"Changing brain networks through non-invasive neuromodulation.","volume":"12","author":"To","year":"2018","journal-title":"Front Hum Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jad.2022.05.107","article-title":"Cortical excitatory and inhibitory correlates of the fronto-limbic circuit in major depression and differential effects of left frontal brain stimulation in a randomized sham-controlled trial.","volume":"311","author":"Li","year":"2022","journal-title":"J Affect Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jad.2019.07.084","article-title":"Feasibility and clinical effects of theta burst stimulation in youth with major depressive disorders: an open-label trial.","volume":"258","author":"Dhami","year":"2019","journal-title":"J Affect Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1176\/appi.ajp.2008.08020247","article-title":"Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.","volume":"166","author":"Bridge","year":"2009","journal-title":"Am J Psychiatry."},{"key":"B31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00787-018-1244-7","article-title":"Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis.","volume":"29","author":"Meister","year":"2020","journal-title":"Eur Child Adolesc Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.853961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:13:18Z","timestamp":1658196798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.853961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":31,"alternative-id":["10.3389\/fpsyt.2022.853961"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.853961","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"article-number":"853961"}}